Skip to main content
Log in

Role of the regional lymph node in cancer metastasis

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

At an early phase of tumor growh, T-cell responses, i.e. the proliferation of T cells and the generation of cytotoxic T cells or killer-augmenting T cells are induced in the regional lymph node depending upon the immunological properties of the tumor cells. A small number of tumor cells seems to be rejected in the regional lymph node in situ. A progressive tumor induces suppressor activity in the regional node. Suppressor cells facilitate tumor growth and lead to lymphatic metastasis. Thus, the regional lymph node operates only as a temporary barrier to tumor growth. Experimental studies have demonstrated that cradication of the suppressor cells and effective immunization, or both, lead to tumor rejection by augmenting the immunological activity of the regional lymph node.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zeidman I, Buss JM: Experimental studies on the spread of cancer in the lymphatic system. I. Effectiveness of the lymph node as a barrier to the passage of embolic tumor cells. Cancer Res 14: 403–405, 1954

    Google Scholar 

  2. Fisher B, Fisher ER: Transmigration of lymph nodes by tumor cells. Science 152: 1397–1398, 1966

    Google Scholar 

  3. Fisher B, Fisher ER: Barrier function of lymph node to tumor cells and erythrocytes. I. Normal nodes. Cancer 20: 1907–1913, 1967

    Google Scholar 

  4. Madden RE, Gyure L: Translymphnodal passage of tumor cells. Oncology 22: 281–289, 1968

    Google Scholar 

  5. Hewitt HB, Blake E: Quantitative studies of translymphnodal passage of tumour cells naturally disseminated from a non-immunogenic murine squamous carcinoma. Br J Cancer 31: 25–35, 1975

    Google Scholar 

  6. Carr J, Carr I, Dreher B, Betts K: Lymphatic metastasis: Invasion of lymphatic vessels and efflux of tumour cells in the afferent popliteal lymph as seen in the Walker rat carcinoma. J Pathol 132: 285–305, 1980

    Google Scholar 

  7. Kripke ML: Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Res 34: 69–106, 1981

    Google Scholar 

  8. Naor D: Suppressor cells: permitters and promotors of malignancy? Adv Cancer Res 29: 45–125, 1979

    Google Scholar 

  9. Haubeck HD, Kölsch E: Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADK-PC-5 during early stages of tumorigenesis. Immunology 47: 503–510, 1982

    Google Scholar 

  10. Carr I: Lymphatic metastasis. Cancer Metastasis Rev 2: 307–317, 1983

    Google Scholar 

  11. Black MM, Kerpe S, Speer FD: Lymph node structure in patients with cancer of the breast. Am J Pathol 24: 505–521, 1953

    Google Scholar 

  12. Tsakraklides V, Olson P, Kersey JH, Good RA: Prognostic significance of regional lymph node histology in cancer of the breast. Cancer 34: 1259–1267, 1974

    Google Scholar 

  13. Black MM, Opler SR, Speer FD: Structural representatives of tumor-host relationships in gastric carcinoma. Surg Gynecol Obstet 102: 599–603, 1956

    Google Scholar 

  14. Black MM, Freeman C, Mork T, Harvei S, Cutler SJ: Prognostic significance of microscopic structure of gastric carcinoma and their regional lymph node. Cancer 27: 703–711, 1971

    Google Scholar 

  15. McDivitt RW: Breast carcinoma. Hum Pathol 9: 3–21, 1978

    Google Scholar 

  16. Shevach EM: Macrophages and other accessory cells. In: Paul WE (ed): Fundamental immunology. Raven Press, New York, 1984, pp 71–107

    Google Scholar 

  17. Kelly RH, Balfour BM, Armstrong JA, Griffiths S: Functional anatomy of lymph nodes. II. Peripheral lymph borne mononuclear cells. Anat Rec 190: 5–22, 1978

    Google Scholar 

  18. Steinman RM, Kaplan G, Witmer MD, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J Exp Med 149: 1–16, 1979

    Google Scholar 

  19. Unanue ER: Antigen-presenting function of the macrophage. Ann Rev Immunol 2: 395–428, 1984

    Google Scholar 

  20. de Sousa M: Lymhocyte Circulation. Experimental and Clinical Aspects. John Wiley & Sons, New York, 1981, p 32

    Google Scholar 

  21. Carr I, McGinty F: Lymphatic metastasis and its inhibition: An experimental model. J Pathol 113: 85–95, 1974

    Google Scholar 

  22. van den Oord JJ, de Wolf-Peeters C, Desmet VJ: The paracortical area in reactive lymph nodes demonstrating sinus histiocytosis. Virchows Arch (Cell Pathol) 48: 77–85, 1985

    Google Scholar 

  23. Kamperdijk EWA, van den Berg M, Hoefsmit ECM: Lymph node accessory cells in the immune response. The primary response to paratyphoid vaccine in rat parathymic lymph nodes. Cell Tissue Res 237: 39–42, 1984

    Google Scholar 

  24. Carr I, Carr J, Dreher B: Lymphatic metastasis of mammary adenocarcinoma. An experimental study in the rat with a brief review of the literature. Invasion Metastasis 1: 34–53, 1981

    Google Scholar 

  25. Kurokawa Y: Experiments on lymph node metastasis by intralymphatic inoculation of rat ascites tumor cells, with special reference to lodgement, passage, and growth of tumor cells in lymph nodes. GANN 61: 461–471, 1970

    Google Scholar 

  26. Grandmann E, Vollmer E: Early local reaction and lymph node permeation of rat carcinoma HH9-cl 14 cells. An immunohistological approach. Pathol Res Pract 178: 304–309, 1985

    Google Scholar 

  27. CrileJr G: Rationale of simple mastectomy without radiation for clinical stage 1 cancer of the breast. Surg Gynecol Obstet 120: 975–982, 1965

    Google Scholar 

  28. Crile GJr: The effect on metastasis of removing or irradiating regional nodes of mice. Surg Gynecol Obstet 126: 1270–1272, 1968

    Google Scholar 

  29. Bard DS, Hammond WG, Pilch YH: The role of the regional lymph nodes in the immunity to a chemically induced sarcoma in C3H mice. Cancer Res 29: 1379–1384, 1969

    Google Scholar 

  30. Hammond WG, Rolley RT: Retained regional lymph nodes: Effect on metastases and recurrence after tumor removal. Cancer 25: 368–372, 1970

    Google Scholar 

  31. Fisher B, Fisher ER: Studies concerning the regional lymph node in cancer. I. Initiation of immunity. Cancer 27: 1001–1004, 1971

    Google Scholar 

  32. Fisher B, Fisher ER: Studies concerning the regional lymph node in cancer. II. Maintenance of immunity. Cancer 29: 1496–1501, 1972

    Google Scholar 

  33. Finlay-Jones JJ, Bartholomaeus WN, Fimmel PJ, Keast D, Stanley NV: Biologic and immunologic studies on a murine model of regional lymph node metastasis. J Natl Cancer Inst 64: 1363–1372, 1980

    Google Scholar 

  34. Mitchison NA: Passive transfer of transplantation immunity. Proc Roy Soc Biol 142: 72–87, 1954

    Google Scholar 

  35. Flannery GR, Chalmers PJ, Rolland JM, Nairn RC: Immune response to a syngeneic rat tumour: Development of regional node lymphocyte anergy. Br J Cancer 28: 118–122, 1973

    Google Scholar 

  36. Hellström KE, Hellström I: Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol 18: 209–277, 1974

    Google Scholar 

  37. Goldfarb PM, Hardy MA: The immunologic responsiveness of regional lymphocytes in experimental cancer. Cancer 35: 778–783, 1975

    Google Scholar 

  38. Barna B, Deodhar SD: The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors. Cancer Res 35: 920–926, 1975

    Google Scholar 

  39. Barna B, Deodhar SD: Immunological activity of regional lymph nodes in tumor-bearing mice. Cancer Res 39: 2711–2717, 1979

    Google Scholar 

  40. Tada T: Help, suppression, and specific factors. In: Paul WE (ed): Fundamental immunology. Raven Press, New York, 1984, pp 481–517

    Google Scholar 

  41. Yoshida K, Tachibana T: The primary immunoregulatory role of regional lymph nodes on the development of local tumor and lymphatic metastasis. In: Torisu M, Yoshida T (eds): Basic mechanisms and clinical treatment of tumor metastasis. Academic Press. Orlando, 1985, pp 355–369

    Google Scholar 

  42. Yoshida K, Tachibana T: Studies on lymphatic metastasis. I. Primary immunoregulatory role of regional lymph nodes in the establishment of lymphatic metastases. J Natl Cancer Inst 75: 1049–1058, 1985

    Google Scholar 

  43. Yoshida K, Tachibana T: Tumor heterogeneity and lymphatic metastasis. Kokenshi 37: 183–191, 1985

    Google Scholar 

  44. Hashimoto K: Studies on metastasis of cancer. 18. Experiments on lymph nodes metastasis with reference to preventive effect of surgical removal of the regional lymph nodes on recurrence and metastasis. Sci Rep Res Inst Tohoku Univ C 11: 406–418, 1964

    Google Scholar 

  45. Weinhold KJ, Miller DA, Wheelock EF: The tumor dormant state. Comparison of L5178Y cell used to establish dormancy with those that emerge after its termination. J Exp Med 149: 745–757, 1979

    Google Scholar 

  46. Ishibashi T, Yamada H, Harada H, Harada Y, Miyazaka N, Takemoto M, Watanabe K: Distant metastasis facilitated by BCG: Spread of tumor cells injected in the BCG-primed site. Br J Cancer 41: 553–561, 1980

    Google Scholar 

  47. Green MI: The genetic and cellular basis of regulation of the immune response to tumor antigens. In: Warner NL (ed): Contemporary topics in immunobiology, Vol 11. Plenum Press, New York, 1980, pp 81–116

    Google Scholar 

  48. Greenberg PD, Cheever MA, Fefer A: Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-l-2+ lympohocytes. J Exp Med 154: 952–963, 1981

    Google Scholar 

  49. Fujiwara H, Takai Y, Sakamoto K, Hamaoka T: The mechanism of tumor growth inhibition by tumor-specific Lyt-l+2- T cells. I. Antitumor effect of Lyt-l+2- T cells depends on the existence of adherent cells. J Immunol 135: 2187–2191, 1985

    Google Scholar 

  50. Riccardi C, Santoni A, Barlozzari T, Puccetti P, Herberman RB: In vivo natural reactivity of mice against tumor cells. Int J Cancer 25: 475–486, 1980

    Google Scholar 

  51. Matzku S: Natural cytotoxicity in lymphatic metastasis. II. In vivo studies with BSp73 variants differing in metastatic capacity. Cancer Immunol Immunother 17: 106–111, 1984

    Google Scholar 

  52. Fidler IJ, Kripke ML: Metastasis results from pre-existing variant cells within a malignant tumor. Science 197: 893–895, 1977

    Google Scholar 

  53. Nicolson GL, Brunson KW, Fidler IJ: Specificity of arrest, survival and growth of selected metastatic variant cell lines. Cancer Res 38: 4105–4111, 1978

    Google Scholar 

  54. Neri A, Welch D, Kawaguchi T, Nicolson GL: Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 68: 507–517, 1982

    Google Scholar 

  55. Weiss L, Holmes JC, Ward PM: Do metastases arise from pre-existing subpopulation of cancer cells? Br J Cancer 47: 81–89, 1983

    Google Scholar 

  56. Kodoma T, Gotohda E, Takeichi N, Kuzumaki N, Kobayashi H: Histopathology of immunologic regression of tumor metastasis in the lymph nodes. J Natl Cancer Ins 52: 931–939, 1974

    Google Scholar 

  57. Kreider JW, Bartlett GL: Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma. J Natl Cancer Inst 75: 141–149, 1985

    Google Scholar 

  58. North RJ, Bursuker I: Generation and decay of the immune response to a progressive fibrosarcoma. I. Lyt-l+2- suppressor T cells down-regulate the generation of Lyt-l-2+ effector T cells. J Exp Med 159: 1295–1311, 1984

    Google Scholar 

  59. Kripke ML: Immunological unresponsiveness induced by ultraviolet radiation. Immunol Rev 80: 87–102, 1984

    Google Scholar 

  60. Granstein RD, Lowy A, Greene MI: Epidermal antigen-presenting cells in activation of suppression: Identification of a new functional type of ultraviolet radiation-resistant epidermal cell. J Immunol 132: 563–565, 1984

    Google Scholar 

  61. Loveland BE, Hogarth PM, Ceredig RH, McKenzie IFC: Cells mediating graft rejection in the mouse. I. Lyt-l cells mediate skin graft rejection. J Exp Med 153: 1044–1057, 1981

    Google Scholar 

  62. Titus RG, Ceredig R, Cerottini JC, Louis JA: Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol 135: 2108–2114, 1985

    Google Scholar 

  63. Ljunggren HG, Kärre K: Host resistance directed selectively against H-2-deficient lymphoma variants. J Exp Med 162: 1745–1759, 1985

    Google Scholar 

  64. Piontek GE, Taniguchi K, Ljunggren HG, Grönberg A, Kiessling R, Klein G, Kärre K: YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J Immunol 135: 4281–4288, 1985

    Google Scholar 

  65. Wallich R, Bulbuc N, Hämmerling GJ, Katzav S, Segal S, Feldman M: Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 315: 301–305, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tachibana, T., Yoshida, K. Role of the regional lymph node in cancer metastasis. Cancer Metast Rev 5, 55–66 (1986). https://doi.org/10.1007/BF00046422

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00046422

Keywords

Navigation